IFNA1 and COVID-19: All these data indicate that the interplay between the virus replication and the IFN expression plays a critical role in the COVID-19 course and pose the basis for the therapeutic benefit of type I IFN administration in selected patients early in the course of SARS-CoV-2 infection, as a later time may turn detrimental [38,39].